Seeking Alpha

Clovis Oncology falls after pricing stockholder offering at discount

  • Clovis Oncology (CLVS) announces the pricing of a 2M share public offering by selling stockholders.
  • The price to the public is $57.50, a 2.4% discount to Tuesday's close.
  • CLVS -1.6% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs